trovafloxacin has been researched along with Disease Models, Animal in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (36.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, HS; Brooks, TJ; Kenny, DJ; Sefton, AM; Simpson, AJ; Steward, J | 1 |
| Atkins, HS; Brew, SD; Brooks, TJ; Jenner, DC; MacMillan, AP; Sefton, AM; Simpson, AJ; Spencer, S | 1 |
| Atkins, HS; Brooks, TJ; Kenny, DJ; Laws, TR; Sefton, AM; Simpson, AJ | 1 |
| Ganey, PE; Roth, RA; Shaw, PJ | 1 |
| Nathan, BR; Scheld, WM | 1 |
| Barequet, IS; Denton, P; O'Brien, TP; Osterhout, GJ; Tuli, S | 1 |
| Gentry-Nielsen, MJ; Olsen, KM; Preheim, LC; Snitily, MU; Yue, M | 1 |
| Ganey, PE; Hopfensperger, MJ; Roth, RA; Shaw, PJ | 1 |
| Brück, W; Fischer, FR; Nau, R; Schmidt, H; Stringaris, AK; Stuertz, K; Zysk, G | 1 |
| Bayer, AS; Ing, M; Li, C | 1 |
| Baker, AS; Cousins, FV; D'Amico, DJ; Hooper, DC; Ng, EW; Ruoff, KL; Samiy, N; von Gunten, S | 1 |
| Onderdonk, AB | 1 |
| Cottagnoud, M; Cottagnoud, P; Gerber, CM; Hänni, F; Neftel, K; Rodoni, D; Täuber, MG | 1 |
| Gentry, MJ; Olsen, KM; Preheim, LC; Snitily, MU; Yue, M | 1 |
| Bastero, R; Friedland, IR; Jafri, HS; Lutsar, I; McCoig, CC; McCracken, GH; Olsen, K; Shelton, S; Wubbel, L | 1 |
| Friedland, IR; Ghaffar, F; Jafri, H; Lutsar, I; McCracken, GH; Ng, W; Wubbel, L | 1 |
| Eiffert, H; Mäder, M; Nau, R; Schmidt, H; Stuertz, K; Trostdorf, F | 1 |
| Coyle, EA; Hershberger, E; Kaatz, GW; Rybak, MJ; Zervos, MJ | 1 |
| Acosta, F; Cottagnoud, M; Cottagnoud, P; Neftel, K; Täuber, MG | 1 |
| Patel, R; Piper, KE; Ronningen, KL; Rouse, MS; Steckelberg, JM; Wilson, WR | 1 |
| Giamarellou, H; Iliopoulos, D; Karayiannakos, P; Katsarolis, I; Pefanis, A; Siaperas, P | 1 |
| McCracken, GH | 1 |
| Goessens, WH; Gyssens, IC; Mouton, JW; Oyen, WJ; Stearne, LE; van der Meer, JW; Verbrugh, HA | 1 |
| Cortés Sanchez, R; García Alberola, A; Gómez Gómez, J; López Fornas, F; Martínez García, F; Pérez Salmeron, J; Roldán Conesa, D; Ruíz Gómez, J; Valdés Chávarri, M | 1 |
| Toyoda, T; Wanibuchi, H; Wei, M; Yamada, T; Yamano, S | 1 |
2 review(s) available for trovafloxacin and Disease Models, Animal
| Article | Year |
|---|---|
Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.
Topics: Animals; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Drug-Related Side Effects and Adverse Reactions; Fluoroquinolones; Humans; Inflammation; Naphthyridines; Stress, Physiological | 2010 |
Pharmacodynamics of gatifloxacin in experimental models of pneumococcal meningitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Child; Disease Models, Animal; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Fluoroquinolones; Gatifloxacin; Humans; Meningitis, Pneumococcal; Naphthyridines; Rabbits; Streptococcus pneumoniae; Vancomycin | 2000 |
23 other study(ies) available for trovafloxacin and Disease Models, Animal
| Article | Year |
|---|---|
Efficacy of the quinolones trovafloxacin and grepafloxacin for therapy of experimental tularaemia and plague.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Fluoroquinolones; Mice; Mice, Inbred BALB C; Naphthyridines; Piperazines; Plague; Treatment Outcome; Tularemia | 2009 |
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Brucella melitensis; Brucellosis; Colony Count, Microbial; Disease Models, Animal; Female; Fluoroquinolones; Humans; Mice; Mice, Inbred BALB C; Naphthyridines; Piperazines; Spleen | 2010 |
Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosis.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Burkholderia pseudomallei; Disease Models, Animal; Female; Fluoroquinolones; Humans; Melioidosis; Mice; Mice, Inbred BALB C; Naphthyridines; Piperazines; Survival Analysis | 2010 |
The efficacy of trovafloxacin versus ceftriaxone in the treatment of experimental brain abscess/cerebritis in the rat.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Brain Abscess; Ceftriaxone; Disease Models, Animal; Female; Fluoroquinolones; Half-Life; Injections, Subcutaneous; Microbial Sensitivity Tests; Naphthyridines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2003 |
Treatment of experimental bacterial keratitis with topical trovafloxacin.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Ciprofloxacin; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Ophthalmic Solutions; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Streptococcal Infections | 2004 |
Effect of cirrhosis on antibiotic efficacy in a rat model of pneumococcal pneumonia.
Topics: Animals; Azithromycin; Biological Availability; Blood Chemical Analysis; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Injections, Subcutaneous; Liver Cirrhosis; Male; Naphthyridines; Pneumonia, Pneumococcal; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Risk Assessment; Sensitivity and Specificity; Survival Rate | 2005 |
Lipopolysaccharide and trovafloxacin coexposure in mice causes idiosyncrasy-like liver injury dependent on tumor necrosis factor-alpha.
Topics: Alanine Transaminase; Animals; Anti-Infective Agents; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Etanercept; Fluoroquinolones; Immunoglobulin G; Inflammation; Levofloxacin; Lipopolysaccharides; Liver; Male; Mice; Mice, Inbred C57BL; Naphthyridines; Ofloxacin; Pentoxifylline; Receptors, Tumor Necrosis Factor; Time Factors; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2007 |
Trovafloxacin delays the antibiotic-induced inflammatory response in experimental pneumococcal meningitis.
Topics: Adult; Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Humans; Injections, Intravenous; Interleukin-1; Lactic Acid; Meningitis, Pneumococcal; Naphthyridines; Rabbits; Streptococcus pneumoniae; Tumor Necrosis Factor-alpha | 1997 |
Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Endocarditis, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Oxacillin; Penicillins; Rabbits; Staphylococcal Infections; Staphylococcus | 1998 |
Treatment of experimental Staphylococcus epidermidis endophthalmitis with oral trovafloxacin.
Topics: Administration, Oral; Animals; Anterior Eye Segment; Anti-Infective Agents; Biological Availability; Colony Count, Microbial; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Male; Microbial Sensitivity Tests; Naphthyridines; Rabbits; Random Allocation; Retina; Staphylococcal Infections; Staphylococcus epidermidis; Vitreous Body | 1998 |
Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection.
Topics: Abdominal Abscess; Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteria; Bacteroides fragilis; Biological Availability; Disease Models, Animal; Escherichia coli; Fluoroquinolones; Male; Mice; Naphthyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Surgical Wound Infection | 1998 |
Trovafloxacin in combination with vancomycin against penicillin-resistant pneumococci in the rabbit meningitis model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Drug Therapy, Combination; Fluoroquinolones; Meningitis, Pneumococcal; Naphthyridines; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Time Factors; Vancomycin | 1999 |
Ethanol feeding does not affect the efficacy or pharmacokinetics of azithromycin, trovafloxacin, or ceftriaxone in a rat model of pneumococcal pneumonia.
Topics: Animals; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Ethanol; Feeding Behavior; Fluoroquinolones; Leukocyte Count; Male; Naphthyridines; Neutrophils; Pneumonia, Pneumococcal; Rats; Rats, Sprague-Dawley | 1999 |
Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitis.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cerebrospinal Fluid; Disease Models, Animal; Fluoroquinolones; Half-Life; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Rabbits; Streptococcus pneumoniae | 1999 |
Pharmacodynamics of trovafloxacin in a mouse model of cephalosporin-resistant Streptococcus pneumoniae pneumonia.
Topics: Analysis of Variance; Animals; Anti-Infective Agents; Cephalosporin Resistance; Cephalosporins; Disease Models, Animal; Female; Fluoroquinolones; Lung; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Naphthyridines; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1999 |
Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ceftriaxone; Cephalosporins; Disease Models, Animal; Fluoroquinolones; Immunoenzyme Techniques; Lipopolysaccharides; Meningitis, Pneumococcal; Moxifloxacin; Naphthyridines; Polysaccharides, Bacterial; Quinolines; Rabbits; Reference Values; Rifabutin; Teichoic Acids; Virginiamycin | 1999 |
Comparison of a rabbit model of bacterial endocarditis and an in vitro infection model with simulated endocardial vegetations.
Topics: Animal Testing Alternatives; Animals; Anti-Infective Agents; Blood Platelets; Cattle; Ciprofloxacin; Disease Models, Animal; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Enterococcus; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Naphthyridines; Rabbits; Staphylococcus aureus | 2000 |
Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae | 2000 |
Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Disease Models, Animal; Endocarditis, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Rabbits; Streptococcal Infections; Streptococcus; Treatment Outcome; Vancomycin | 2000 |
Successful trovafloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
Topics: Ampicillin; Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Aortic Valve; Disease Models, Animal; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Diseases; Microbial Sensitivity Tests; Naphthyridines; Penicillins; Rabbits; Streptococcal Infections; Streptococcus | 2000 |
In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.
Topics: Abscess; Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Blood Proteins; Disease Models, Animal; Enterococcus faecium; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Positive Bacterial Infections; Immunoglobulin G; Mice; Mice, Inbred BALB C; Naphthyridines; Treatment Outcome; Vancomycin Resistance | 2001 |
Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple; Endocarditis, Bacterial; Fluoroquinolones; Humans; Male; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 2001 |
Inhibitory effect of Raphanobrassica on Helicobacter pylori-induced gastritis in Mongolian gerbils.
Topics: Animals; Brassicaceae; Chronic Disease; Disease Models, Animal; Gastritis; Gerbillinae; Glucosinolates; Helicobacter Infections; Helicobacter pylori; Imidoesters; Inflammation; Interleukin-6; Male; Oximes; Plant Extracts; RNA, Messenger; Sulfoxides | 2014 |